S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
Log in

NASDAQ:NSTG - NanoString Technologies Stock Price, Forecast & News

$22.86
+0.71 (+3.21 %)
(As of 04/2/2020 04:00 PM ET)
Today's Range
$21.65
Now: $22.86
$23.11
50-Day Range
$16.01
MA: $29.32
$36.04
52-Week Range
$13.85
Now: $22.86
$36.43
Volume384,456 shs
Average Volume619,279 shs
Market Capitalization$845.82 million
P/E RatioN/A
Dividend YieldN/A
Beta1.15
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer and 360 gene expression, CAR-T characterization, protein immune profiling, neuropathology and neuro-inflammation gene expression, Mouse-AD, autoimmune disease gene expression, miRNA expression, and other gene expression panels. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq molecular profiling system to determine and analyze gene sequences within biological samples. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; and Astellas Pharma, Inc, as well as strategic partnership with Bio-Techne Corp. The company was founded in 2003 and is headquartered in Seattle, Washington.
Read More
NanoString Technologies logo

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NSTG
CUSIPN/A
Phone206-378-6266

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$125.57 million
Book Value$2.91 per share

Profitability

Net Income$-40,700,000.00

Miscellaneous

Employees476
Market Cap$845.82 million
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive NSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for NSTG and its competitors with MarketBeat's FREE daily newsletter.


NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

How has NanoString Technologies' stock been impacted by COVID-19 (Coronavirus)?

NanoString Technologies' stock was trading at $30.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NSTG stock has decreased by 25.0% and is now trading at $22.86. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of NanoString Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for NanoString Technologies.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for NanoString Technologies.

How were NanoString Technologies' earnings last quarter?

NanoString Technologies Inc (NASDAQ:NSTG) posted its quarterly earnings data on Wednesday, February, 26th. The biotechnology company reported ($0.59) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.60) by $0.01. The biotechnology company had revenue of $36.93 million for the quarter, compared to the consensus estimate of $35.23 million. NanoString Technologies had a negative return on equity of 78.73% and a negative net margin of 32.41%. View NanoString Technologies' earnings history.

What guidance has NanoString Technologies issued on next quarter's earnings?

NanoString Technologies issued an update on its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $125.7-125.7 million, compared to the consensus revenue estimate of $121.36 million.

What price target have analysts set for NSTG?

1 brokers have issued twelve-month price objectives for NanoString Technologies' shares. Their forecasts range from $35.00 to $35.00. On average, they anticipate NanoString Technologies' stock price to reach $35.00 in the next twelve months. This suggests a possible upside of 53.1% from the stock's current price. View analysts' price targets for NanoString Technologies.

Has NanoString Technologies been receiving favorable news coverage?

Media coverage about NSTG stock has been trending very negative on Thursday, InfoTrie reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. NanoString Technologies earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutNanoString Technologies.

Who are some of NanoString Technologies' key competitors?

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank Of The Ozarks (OZRK) and Eaton Vance Floating-Rate Income Trust (EFT).

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the following people:
  • Mr. R. Bradley Gray, CEO, Pres & Director (Age 42)
  • Mr. K. Thomas Bailey M.B.A., CFO & Treasurer (Age 50)
  • Dr. Mary Tedd Allen, Sr. VP of Operations & Admin. (Age 56)
  • Dr. Joseph M. Beechem, Sr. VP of R&D (Age 61)
  • Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 52)

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $22.86.

How big of a company is NanoString Technologies?

NanoString Technologies has a market capitalization of $845.82 million and generates $125.57 million in revenue each year. The biotechnology company earns $-40,700,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis. NanoString Technologies employs 476 workers across the globe. View additional information about NanoString Technologies.

What is NanoString Technologies' official website?

The official website for NanoString Technologies is http://www.nanostring.com/.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]


MarketBeat Community Rating for NanoString Technologies (NASDAQ NSTG)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  475 (Vote Outperform)
Underperform Votes:  451 (Vote Underperform)
Total Votes:  926
MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe NSTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel